| 1. | | No longer recruiting | "Clinical Trials to Enhance Elders' Oral Health" ("TEETH")
Conditions: Tooth Loss; Periodontal Disease; Tooth decay |
| 2. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors
Condition: Cancer |
| 3. | | Not yet recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 4. | | Not yet recruiting | 3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 5. | | Recruiting | Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer |
| 6. | | Not yet recruiting | Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
| 7. | | Recruiting | Adjuvant Erlotinib After Completing Chemoradiotherapy in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Cancer |
| 8. | | Recruiting | Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 9. | | Recruiting | Administration of EBV-Specific Cytotoxic T-Lymphocytes to Patients with EBV-Positive Cancer of the Nose and Throat
Conditions: Nasopharyngeal Cancer; Epstein-Barr Virus Infections |
| 10. | | No longer recruiting | Alternative Medicine Approaches for Women with Temporomandibular Disorders
Condition: Temporomandibular Joint Disorders |
| 11. | | Completed | Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
Conditions: Endometrial Cancer; ovarian epithelial cancer; Cervical Cancer; uterine sarcoma |
| 12. | | No longer recruiting | Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
Conditions: Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer |
| 13. | | Completed | Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer
Conditions: oral complications of cancer and cancer therapy; stage IV squamous cell carcinoma of the lip and oral cavity; ... |
| 14. | | No longer recruiting | Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the Peritoneum
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 15. | | No longer recruiting | Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
Conditions: Lip Neoplasms; Mouth Neoplasms; Oropharyngeal Cancer; Head and Neck Cancer |
| 16. | | No longer recruiting | Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition: Head and Neck Cancer |
| 17. | | Recruiting | Assessing the Results of Lip Surgery in Patients With Cleft Lip and Palate
Conditions: Cleft Lip; Cleft Palate |
| 18. | | Recruiting | Benzydamine in Treating Radiation-Induced Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Cancer of the Oral Cavity, Oropharynx, and/or Nasopharynx
Conditions: lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer |
| 19. | | Recruiting | Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Condition: Head and Neck Cancer |
| 20. | | Recruiting | Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer |
| 21. | | No longer recruiting | Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 22. | | Recruiting | Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Condition: Head and Neck Cancer |
| 23. | | No longer recruiting | Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Head and Neck Cancer
Conditions: stage IV squamous cell carcinoma of the lip and oral cavity; stage III squamous cell carcinoma of the hypopharynx; ... |
| 24. | | No longer recruiting | Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer |
| 25. | | Recruiting | Biological Specifications for Denture Designs
Condition: Tooth Loss |
| 26. | | No longer recruiting | Biological Therapy in Treating Patients With Metastatic Cancer
Conditions: Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ... |
| 27. | | Suspended | BMS-247550 in Treating Patients With Ovarian Epithelial or Primary Peritoneal Cancer That Has Not Responded to Previous Chemotherapy
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 28. | | Completed | BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ... |
| 29. | | Recruiting | Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
Conditions: Endocrine Cancer; Gastrointestinal Cancer; Head and Neck Cancer; metastatic cancer |
| 30. | | Completed | Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer |
| 31. | | Recruiting | Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck
Conditions: lip and oral cavity cancer; Salivary Gland Cancer |
| 32. | | Recruiting | Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 33. | | Recruiting | Bradykinin Receptors and Pain
Condition: Tooth, Impacted |
| 34. | | Recruiting | Brief Treatment for Temporomandibular Pain
Conditions: Temporomandibular Joint Syndrome; Myofascial Pain Dysfunction Syndrome, Temporomandibular Joint; Orofacial Pain |
| 35. | | No longer recruiting | Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; recurrent ovarian epithelial cancer; Fallopian Tube Cancer; ... |
| 36. | | Completed | Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Conditions: stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ... |
| 37. | | Recruiting | Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer |
| 38. | | Completed | Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer |
| 39. | | No longer recruiting | Capecitabine in Treating Women With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
| 40. | | No longer recruiting | Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
Conditions: Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer |
| 41. | | No longer recruiting | Carboplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer
Conditions: recurrent nasopharyngeal cancer; stage IV nasopharyngeal cancer |
| 42. | | Recruiting | Carboplatin Plus Docetaxel and Paclitaxel in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer |
| 43. | | No longer recruiting | Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer
Conditions: stage I ovarian epithelial cancer; peritoneal cavity cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; ... |
| 44. | | Recruiting | Carboplatin With or Without Liposomal Doxorubicin in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer
Conditions: peritoneal cavity cancer; recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer |
| 45. | | Recruiting | Caries Transmission Prevention in Alaska Native Infants
Condition: Dental Caries |
| 46. | | Not yet recruiting | Celecoxib and/or EKB-569 in Preventing Oral Cancer in Patients With Oral Leukoplakia
Conditions: lip and oral cavity cancer; Salivary Gland Cancer; Precancerous Condition |
| 47. | | Recruiting | Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
Condition: Head and Neck Cancer |
| 48. | | Recruiting | Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
Conditions: Head and Neck Cancer; thorax and respiratory cancer |
| 49. | | No longer recruiting | Celecoxib in Treating Patients With Precancerous Lesions of the Mouth
Conditions: lip and oral cavity cancer; prevention of oral cancer |
| 50. | | Recruiting | Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer |
